200
Participants
Start Date
August 1, 2020
Primary Completion Date
May 10, 2024
Study Completion Date
May 10, 2024
NanoBone Bone Graft Substitute
Synthetic, biodegradable bone grafting material that is composed of non-sintered nanocrystalline hydroxyapatite (HA) which is embedded in a silica gel matrix (amorphous SiO2). The ratio of HA/SiO2 has been chosen to optimize the rate of biodegradation for treatment of osseous defects in human bone. NanoBone does not contain any components of animal or human origin, eliminating the possibility of transmission of infection or disease.
Florida Orthopedic Foot & Ankle Center, Sarasota
Podiatry Associates of Indiana, Indianapolis
Hoosier Foot and Ankle, Kokomo
The Iowa Clinic, West Des Moines
Orthopedic Associates of Duluth, Duluth
Illinois Orthopedic Institute, Joliet
Morrison Hospital, Morrison
Phoenix Foot and Ankle Institute, Scottsdale
Lead Sponsor
Artoss Inc.
INDUSTRY